Global Rhes knockout in the Q175 Huntington's disease mouse model.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Huntington's disease (HD) is a neurodegenerative disorder caused by a mutation in the huntingtin gene, primarily affecting the striatum.
• Rhes, a small GTP-binding protein highly expressed in the striatum, has been implicated in modulating mutant huntingtin's effects.
• Previous studies on Rhes's role in HD pathogenesis have yielded conflicting results regarding the benefits of its reduction.

Purpose of the Study:

• To investigate the impact of genetic Rhes knockout (KO) on behavioral and molecular phenotypes in the Q175 mouse model of Huntington's disease.
• To determine if Rhes deficiency ameliorates or exacerbates HD-related pathology in a comprehensive mouse model.

Main Methods:

• Utilized the Q175 mouse model, a widely accepted model for studying Huntington's disease.
• Generated Rhes knockout (KO) mice in the Q175 background.
• Assessed multiple behavioral, kinematic, and molecular endpoints, including MRI, MRS, DARPP32 levels, mTOR signaling, autophagy, and mutant huntingtin levels.

Main Results:

• Genetic Rhes KO in Q175 female mice showed a mixed impact, with subtle attenuation of some phenotypic features but detrimental effects on others.
• Rhes KO did not influence MRI, MRS, or DARPP32 readouts in Q175 females exhibiting pathogenic deficits.
• In mixed-gender Q175 mice, Rhes KO did not alter mTOR signaling, autophagy, or mutant huntingtin levels.

Conclusions:

• Global Rhes knockout does not significantly ameliorate Huntington's disease phenotypes in the Q175 mouse model.
• The findings suggest that Rhes modulation alone may not be a viable therapeutic strategy for Huntington's disease.
• Further research is needed to fully elucidate the complex role of Rhes in HD pathogenesis.